Completed PHASE2 INTERVENTIONAL 4-arm NCT01822925

Study of DA-9801 to Treat Diabetic Neuropathy

A Phase II Randomized, Double-Blind, Parallel Group, Dose-Ranging, Placebo-Controlled Study to Assess the Safety And Effectiveness Of DA-9801 in the Treatment of Subjects With Diabetic Neuropathy

Sponsor: Dong-A ST Co., Ltd.

Conditions Diabetic Neuropathy

Interventions DA-9801 300mg DA-9801 600mg DA-9801 900mg Placebo

Updated 8 times since 2017 Last updated: Mar 6, 2020 Started: Nov 30, 2013 Primary completion: Jan 31, 2015 Completion: Jan 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01822925, this PHASE2 trial focuses on Diabetic Neuropathy and remains completed. Sponsored by Dong-A ST Co., Ltd., it has been updated 8 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Apr 2020 — Jan 2021 [monthly]

Completed PHASE2

▶ Show 3 earlier versions

Jun 2018 — Apr 2020 [monthly]

Completed PHASE2
Feb 2017 — Jun 2018 [monthly]

Completed PHASE2
Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Nov 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Dong-A ST Co., Ltd.
NeuroBo Pharmaceuticals Inc.

Data source: NeuroBo Pharmaceuticals Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Albany, United States , Baltimore, United States , Brandon, United States , Dallas, United States , Houston, United States , Lakewood, United States , Milford, United States , Mt. Pleasant, United States , New Bedford, United States , Renton, United States and 3 more locations